Related Experiment Videos

Targeting T cell killing with complement component C3-anti CD3 fusion proteins

W Fecke1, M Koukidou, T C Farries

  • 1Imutran Ltd (A Novartis Pharma AG Company), Cambridge, United Kingdom.

Transplantation Proceedings
|September 2, 1998
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos